Navigation Links
Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
Date:5/22/2008

ting effects. Because of its chemical structure, RELISTOR does not affect the opioid-mediated analgesic effects on the CNS.

About Subcutaneous RELISTOR

On April 24, 2008, the United States Food and Drug Administration approved RELISTOR subcutaneous injection for the treatment of OIC in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient. The use of RELISTOR beyond four months has not been studied. Wyeth expects to make subcutaneous RELISTOR available in the United States in early June. Subcutaneous RELISTOR has also been approved in Canada and is awaiting Australian approval and European approval, having received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP), the EMEA scientific committee, in April.

Important Safety Information for Subcutaneous RELISTOR

-- RELISTOR is contraindicated in patients with known or suspected

mechanical gastrointestinal obstruction.

-- If severe or persistent diarrhea occurs during treatment, advise

patients to discontinue therapy with RELISTOR and consult their

physician.

-- Use of RELISTOR has not been studied in patients with peritoneal

catheters.

-- The most common adverse reactions with RELISTOR in clinical trials were

abdominal pain, flatulence, and nausea.

RELISTOR Prescribing Information is available at http://www.relistor.com.

About the Collaboration

In December 2005, Wyeth and Progenics Pharmaceuticals entered into an exclusive, worldwide agreement for the joint development and commercialization of methylnaltrexone for the treatment of opioid-induced side effects.

About the Companies

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
3. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
4. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
5. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
6. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015  In a sweeping analysis assessing ... T1D Exchange researchers conclude that there remains ... diabetes across all age groups, but especially for adolescents ... picture of diabetes treatment, underscoring the need to address ... that can help type 1 patients achieve optimal metabolic ...
(Date:5/22/2015)... , May 22, 2015 AcelRx Pharmaceuticals, Inc. ... on the development and commercialization of innovative therapies for ... that interim chief executive officer Howie Rosen ... chief financial officer Tim Morris will be ... the two presentations are as follows: Jefferies ...
(Date:5/21/2015)... , May 21, 2015 ... ) has announced the addition of the ... Type (Ankle Replacement, Digit Replacement, Elbow Replacement, ... Forecast to 2019" report to their ... for knee replacement was valued at $4,470.9 ...
Breaking Medicine Technology:Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2
... , ROCKVILLE, Md., Dec. 9 Novavax, ... 25, 2009, it closed its previously announced public offering of ... Novavax received net proceeds from the sale of the ... approximately $21 million, which will be used for preclinical studies ...
... , GAITHERSBURG, Md, Dec. 9 Lentigen Corporation, ... of lentiviral gene delivery technologies, announced today that it ... business innovation research (SBIR) grant for a program on ... using Lentivirus". In this program, Lentigen will collaborate ...
Cached Medicine Technology:NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2
(Date:5/23/2015)... With the implementation of the Affordable Care ... difficult to provide their employees with a viable healthcare ... for employees stand to face strict penalties. Never before ... of a business’s success or failure. In an effort ... Doctors has created a varying level of less expensive ...
(Date:5/23/2015)... May 23, 2015 Javon Bea ... the Sports Medicine and Rehabilitation Center, 557 N. Washington ... Mondays, June 1-July 20, 5:30-6:30 pm. , The 8-week ... and Laurie Finke, RN, BSN, who will offer training ... on nutrition, running mechanics and show selection and weekly ...
(Date:5/22/2015)... May 22, 2015 The American College ... events in June. They will hold a webinar on ... a two-day class on Classical Chinese Medicine. , Webinar ... Dr. Steve Given, the Dean of Clinical Education, will ... new First Professional Doctorate program. ACTCM is currently developing ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Omar Ahmad ... selected to participate in the 2015 Congress of Future ... described as a gathering of “America’s highest achieving high ... areas of healthcare, set new goals and learn better ... a live surgery, during which we can ask the ...
(Date:5/22/2015)... Pa (PRWEB) May 22, 2015 ... (AHN) today announced a new partnership to develop ... for the region. The initiative includes a new exhibit ... live demonstration theater, and a new traveling science ... the fall of 2015. , Designed to explore ...
Breaking Medicine News(10 mins):Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:ACTCM Announces Upcoming June Events 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4
... , Jan. 13 WellPoint, Inc. (NYSE: ... a "2010 Diversity Leader Award®" in the January/February issue of ... communication practices during the past year. , WellPoint continues ... inclusion practices and has received multiple honors in recent years ...
... ... products direct to patients which will reduce operating costs for providers and improve patient ... Plainview, ... announced today a strategic alliance designed to automate the shipping of CPAP products ...
... ... your health , ... the gym and cheaper than cosmetic surgery or even your nighttime moisturizer, turning up the heat ... and your health., , , , ,“An active sex life will make you healthier, buffer, younger ...
... ... advertising executive launches RedSquare360 to accommodate manufacturers, and web retailers, growing demands for 3D ... to help ecommerce clients increase conversion rates. , ... (PRWEB) January 13, 2010 -- Online retailers know the ...
... ... Microbix will maintain sales and marketing functions while Therapure will manage manufacturing, distribution ... ... Biosystems Inc. (MBX:TSX) a biotechnology company focused on virology and biological technologies, and ...
... ... firm striving to help families with wide range of legal needs. , ... New Brunswick, N.J. (Lexis Nexis) January 13, 2010 ... resources and skilled legal professionals that will help them navigate the state,s court system, ...
Cached Medicine News:Health News:WellPoint, Inc. Receives 2010 Diversity Leader Award(R) 2Health News:WellPoint, Inc. Receives 2010 Diversity Leader Award(R) 3Health News:Fastrack & cpapdropship.com Form Alliance to Reduce Provider Costs 2Health News:Fastrack & cpapdropship.com Form Alliance to Reduce Provider Costs 3Health News:Frequent and Fabulous Sex -- A Menopausal Woman's Surprising Fountain of Youth 2Health News:Frequent and Fabulous Sex -- A Menopausal Woman's Surprising Fountain of Youth 3Health News:360 Images Give Online Consumers A Product 'Demo' Before Purchasing. 2Health News:360 Images Give Online Consumers A Product 'Demo' Before Purchasing. 3Health News:Microbix and Therapure Biopharma Form Partnership to Expand Water-Based Supplies to the Pharma Industry 2Health News:Microbix and Therapure Biopharma Form Partnership to Expand Water-Based Supplies to the Pharma Industry 3Health News:Shamy & Shamy Launches New Web Site Providing Simple Access to Free Online Resources for New Jersey Court System 2
Serology provides a minimally-invasive, sensitive and easy-to-perform method for the determination of H. pylori infection. The Bio-Rad H. pylori qualitative test kits use EIA technology for the deter...
... effective and relatively bloodless procedure for immediate ... to learn and can be performed in ... setting with few if any patient complications. ... OR time and use a familiar technology ...
... IFA Test kit is a user-friendly ... in dropper bottles. A single monoclonal ... identify all serogroups of L. pneumophilia ... culture isolates, confirming a diagnosis of ...
... of the most innovative and elegantly simple ... provides an ideal solution for physicians seeking ... other option provides a better combination of ... System heats, circulates, and maintains precise control ...
Medicine Products: